These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6024508)

  • 1. The use of immunologically competent cells in the treatment of cancer. Further experiments with a transplantable mouse tumour.
    Symes MO
    Br J Cancer; 1967 Mar; 21(1):178-83. PubMed ID: 6024508
    [No Abstract]   [Full Text] [Related]  

  • 2. Attempts to induce a graft-versus-tumour reaction against AKR lymphomata, in isogenic mice, by injection of Melphalan and foreign immunologically competent cells.
    Denton PM; Symes MO
    Br J Cancer; 1969 Mar; 23(1):95-102. PubMed ID: 5768449
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of immunologically competent cells in the treatment of cancer: experiments with a transplantable mouse tumour.
    WOODRUFF MF; SYMES MO
    Br J Cancer; 1962 Dec; 16(4):707-15. PubMed ID: 14001798
    [No Abstract]   [Full Text] [Related]  

  • 4. Humoral and cellular immune factors in the systemic control of artifically induced metastases in C3Hf mice.
    Vaage J
    Cancer Res; 1973 Aug; 33(8):1957-65. PubMed ID: 4720805
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterotransplantation of mouse tumors to immunologically paralyzed rats.
    Suciu-Foca N
    Cancer Res; 1969 Feb; 29(2):338-48. PubMed ID: 4885388
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of mammary tumor virus infection on the acceptance or rejection of transplanted ML+ leukemias.
    Nowinski RC; Boyse EA; Old LJ; Carswell EA
    Proc Soc Exp Biol Med; 1968 Jan; 127(1):20-5. PubMed ID: 4296245
    [No Abstract]   [Full Text] [Related]  

  • 7. Protection against mammary tumors in mice by immunization with purified mammary tumor virus preparations.
    Burton DS; Blair PB; Weiss DW
    Cancer Res; 1969 Apr; 29(4):971-3. PubMed ID: 4304735
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological studies on mouse mammary tumors. IV. Extraction and solubilization of transplantation antigen of mouse mammary tumor.
    Irie RF; Nishioka K; Tachibana T; Takeuchi S
    Int J Cancer; 1969 Mar; 4(2):150-8. PubMed ID: 5347284
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological studies on mouse mammary tumors. I. Induction of resistance to tumor isograft in C3H/He mice.
    Nishioka K; Irie RF; Inoue M; Chang S; Takeuchi S
    Int J Cancer; 1969 Mar; 4(2):121-9. PubMed ID: 4899787
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of the mammary tumor virus in the immunogenicity of spontaneous mammary carcinomas of BALB/c mice and in the responsiveness of the hosts.
    Dezfulian M; Zee T; DeOme KB; Blair PB; Weiss DW
    Cancer Res; 1968 Sep; 28(9):1759-72. PubMed ID: 4300220
    [No Abstract]   [Full Text] [Related]  

  • 11. Further observations on whether host immunodepression is associated with tumour growth in mice.
    Rees JA; Symes MO
    Br J Cancer; 1971 Sep; 25(3):501-4. PubMed ID: 4401359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of polyinosinic:polycytidylic acid on the growth of transplantable mouse mammary carcinoma.
    Potmesil M; Goldfeder A
    Proc Soc Exp Biol Med; 1972 Apr; 139(4):1392-7. PubMed ID: 5023340
    [No Abstract]   [Full Text] [Related]  

  • 13. Further observations on the growth of mouse mammary carcinomata in the strain of origin. Attempts to transfer adoptive immunity against the tumour, to isogenic hosts, with spleen cells from tumour-bearing mice.
    Symes MO
    Br J Cancer; 1966 Jun; 20(2):356-60. PubMed ID: 5944277
    [No Abstract]   [Full Text] [Related]  

  • 14. Host immune potentiation of drug responses to a murine mammary adenocarcinoma. II. Effect of melphalan therapy on the host immune system.
    Radov LA; Korn JH; Haskill JS
    Int J Cancer; 1976 Nov; 18(5):630-8. PubMed ID: 992900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonvirus-associated antigens in virus-induced mouse mammary tumors.
    Vaage J
    Cancer Res; 1968 Dec; 28(12):2477-83. PubMed ID: 4302532
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigenic cross-reactivity between primary spontaneous mouse mammary tumors and their transplantable ascites tumors.
    Irie RF
    Cancer Res; 1971 Nov; 31(11):1682-9. PubMed ID: 4330634
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro studies on tumor-specific immunity by using C3H mammary cancer-A cells. I. Inhibitory effect of lymph-node cells from the tumor bearing isologous C3H mouse on the proliferation of the tumor cells.
    Satoh K
    Acta Med Okayama (1952); 1966 Dec; 20(6):261-8. PubMed ID: 4227190
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunology of spontaneous mammary carcinomas in mice: immunogenicity of mammary tumor virus-contaning tissues in mammary tumor virus-free C3H-2 hosts.
    Lavrin DH
    Cancer Res; 1970 Apr; 30(4):1156-62. PubMed ID: 4323351
    [No Abstract]   [Full Text] [Related]  

  • 19. [Different effects of early thymectomy on the development of transplanted mammary neoplasms in relation to the presence of the milk factor in the recipients].
    Gruntenko V; Videlets IIu; Sukhov VS
    Dokl Akad Nauk SSSR; 1972 Jul; 205(1):218-9. PubMed ID: 4343378
    [No Abstract]   [Full Text] [Related]  

  • 20. Observations on whether immunodepression is associated with the presence of a tumour in mice.
    Rees JA; Symes MO
    Br J Surg; 1971 Nov; 58(11):862-3. PubMed ID: 5166403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.